1782532-06-2
Chemical Structure
PD 168568 dihydrochloride
- CAS No.: 1782532-06-2
- Formula:C22H29Cl2N3O
- Molecular Weight:422.39
IUPAC Name: 3-(2-(4-(3,4-dimethylphenyl)piperazin-1-yl)ethyl)isoindolin-1-one dihydrochloride
InChIKey: RMNWLEGGYCVHFD-UHFFFAOYSA-N
SMILES: O=C1NC(CCN2CCN(C3=CC=C(C)C(C)=C3)CC2)C4=C1C=CC=C4.[H]Cl.[H]Cl
Biological Activity: PD 168568 dihydrochloride is a orally active and potent dopamine receptor D4 (DRD4) antagonist. PD 168568 dihydrochloride contains an isoindolinone and is selective for the D4 receptor versus D2 and D3, with Ki values of 8.8, 1842, and 2682 nM, respectively. PD 168568 dihydrochloride can be used for glioblastoma (GBM) research[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PD 168568 dihydrochloride | 99.71% | PD 168568 dihydrochloride is a orally active and potent dopamine receptor D4 (DRD4) antagonist. PD 168568 dihydrochloride contains an isoindolinone and is selective for the D4 receptor versus D2 and D3, with Ki values of 8.8, 1842, and 2682 nM, respectively. PD 168568 dihydrochloride can be used for glioblastoma (GBM) research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.97
HY-103407PD 168568 -
Similarity Score 0.55
HY-101690QF0301B -
Similarity Score 0.55
HY-19818NAN-190 -
Similarity Score 0.54
HY-19818ARNAN-190 hydrobromide (Standard) -
Similarity Score 0.53
HY-103132PNU109291 -
Similarity Score 0.53
HY-103131PNU-142633 -
Similarity Score 0.53
HY-10861D3/5-HT receptor modulator-1 -
Similarity Score 0.52
HY-12709RARC 239 (Standard) -
Similarity Score 0.52
HY-12709AARC 239 dihydrochloride -
Explore the MedChemAI to find more analogs
References
- [1]. Dolma S, et al. Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells. Cancer Cell. 2016 Jun 13;29(6):859-873. [Content Brief]
- [2]. Lindsley CW, et al. Return of D4 Dopamine Receptor Antagonists in Drug Discovery. J Med Chem. 2017 Sep 14;60(17):7233-7243. [Content Brief]
